These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33560717)

  • 61. A Multicenter Prospective Clinical Trial of
    McCarthy M; Francis R; Tang C; Watts J; Campbell A
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):801-808. PubMed ID: 30890448
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Correlation between molecular tumor volume evaluated with
    Medina-Ornelas Sevastián S; García-Pérez Francisco O; Hernández-Pedro Norma Y; Arellano-Zarate Angélica E; Abúndiz-López Blanca L
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(4):223-228. PubMed ID: 29454548
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dual-phase 68Ga-PSMA-11 PET/CT may increase the rate of detected lesions in prostate cancer patients.
    Dadgar H; Seyedi Vafaee M; Norouzbeigi N; Jafari E; Gholamrezanezhad A; Assadi M
    Urologia; 2021 Nov; 88(4):355-361. PubMed ID: 33627056
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of
    Sonni I; Eiber M; Fendler WP; Alano RM; Vangala SS; Kishan AU; Nickols N; Rettig MB; Reiter RE; Czernin J; Calais J
    J Nucl Med; 2020 Aug; 61(8):1153-1160. PubMed ID: 31924715
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Multiphasic
    Beheshti M; Manafi-Farid R; Geinitz H; Vali R; Loidl W; Mottaghy FM; Langsteger W
    J Nucl Med; 2020 Oct; 61(10):1484-1490. PubMed ID: 32060214
    [TBL] [Abstract][Full Text] [Related]  

  • 66.
    Cytawa W; Seitz AK; Kircher S; Fukushima K; Tran-Gia J; Schirbel A; Bandurski T; Lass P; Krebs M; Połom W; Matuszewski M; Wester HJ; Buck AK; Kübler H; Lapa C
    Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):168-177. PubMed ID: 31529265
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Biodistribution of [(68)Ga]PSMA-HBED-CC in Patients with Prostate Cancer: Characterization of Uptake in Normal Organs and Tumour Lesions.
    Prasad V; Steffen IG; Diederichs G; Makowski MR; Wust P; Brenner W
    Mol Imaging Biol; 2016 Jun; 18(3):428-36. PubMed ID: 27038316
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An Update on the Role of mpMRI and
    Bagheri H; Mahdavi SR; Geramifar P; Neshasteh-Riz A; Sajadi Rad M; Dadgar H; Arabi H; Zaidi H
    Clin Genitourin Cancer; 2024 Jun; 22(3):102076. PubMed ID: 38593599
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In primary lymph nodal staging of patients with high-risk and intermediate-risk prostate cancer, how critical is the role of Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography?
    Kulkarni SC; Sundaram PS; Padma S
    Nucl Med Commun; 2020 Feb; 41(2):139-146. PubMed ID: 31714366
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pilot study comparing dominant intraprostatic lesion volume using Ga-68 prostate-specific membrane antigen PET-computed tomography and multiparametric MRI.
    Sasidharan A; Murthy V; Natarajan A; Agarwal A; Ranagrajan V; Gudi S; Singh S; Popat P
    Nucl Med Commun; 2020 Dec; 41(12):1291-1298. PubMed ID: 32941400
    [TBL] [Abstract][Full Text] [Related]  

  • 71. PSMA whole-body tumor burden in primary staging and biochemical recurrence of prostate cancer.
    Santos A; Mattiolli A; Carvalheira JB; Ferreira U; Camacho M; Silva C; Costa F; Matheus W; Lima M; Etchebehere E
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):493-500. PubMed ID: 32789680
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Impact of uptake time on image quality of [
    van der Sar ECA; Viol SLM; Braat AJAT; van Rooij R; Lam MGEH; de Jong HWAM; de Keizer B
    Med Phys; 2023 Dec; 50(12):7619-7628. PubMed ID: 37093883
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Significance of metabolic tumor volume and total lesion uptake measured using Ga-68 labelled prostate-specific membrane antigen PET/CT in primary staging of prostate cancer.
    Kubilay E; Akpinar Ç; Oǧuz ES; Araz MS; Soydal Ç; Baltacı S; Ürün Y; Süer E
    Urol Oncol; 2022 Sep; 40(9):408.e19-408.e25. PubMed ID: 35902300
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.
    van Leeuwen PJ; Emmett L; Ho B; Delprado W; Ting F; Nguyen Q; Stricker PD
    BJU Int; 2017 Feb; 119(2):209-215. PubMed ID: 27207581
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of 68GA-PSMA PET / CT on treatment of patients with recurrent / metastatic high risk prostate cancer - a multicenter study.
    Mattiolli AB; Santos A; Vicente A; Queiroz M; Bastos D; Herchenhorn D; Srougi M; Peixoto FA; Morikawa L; da Silva JLF; Etchebehere E
    Int Braz J Urol; 2018; 44(5):892-899. PubMed ID: 30088720
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Relationships between serum PSA levels, Gleason scores and results of 68Ga-PSMAPET/CT in patients with recurrent prostate cancer.
    Sanli Y; Kuyumcu S; Sanli O; Buyukkaya F; İribaş A; Alcin G; Darendeliler E; Ozluk Y; Yildiz SO; Turkmen C
    Ann Nucl Med; 2017 Nov; 31(9):709-717. PubMed ID: 28900854
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    Ceci F; Castellucci P; Graziani T; Farolfi A; Fonti C; Lodi F; Fanti S
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):31-39. PubMed ID: 30350010
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Incremental Impact of [
    Szigeti F; Schweighofer-Zwink G; Meissnitzer M; Hauser-Kronberger C; Hitzl W; Kunit T; Forstner R; Pirich C; Beheshti M
    Mol Imaging Biol; 2022 Feb; 24(1):50-59. PubMed ID: 34519966
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 68Ga-PSMA Uptake in Brain Metastasis of Gastric Carcinoma.
    Kesim S; Oksuzoglu K
    Clin Nucl Med; 2022 Sep; 47(9):e585-e586. PubMed ID: 35930713
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Early Injection of Furosemide Increases Detection Rate of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for
    Uprimny C; Bayerschmidt S; Kroiss AS; Fritz J; Nilica B; Svirydenka H; Decristoforo C; von Guggenberg E; Horninger W; Virgolini IJ
    J Nucl Med; 2021 Nov; 62(11):1550-1557. PubMed ID: 33712533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.